2-(N-anilino)-3-pyrrolidino-1,4-naphthoquinone | 465547-43-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-(N-anilino)-3-pyrrolidino-1,4-naphthoquinone
• 英文别名: 2-Anilino-3-pyrrolidin-1-ylnaphthalene-1,4-dione
• CAS: 465547-43-7
• 化学式: C₂₀H₁₈N₂O₂
• 分子量: 318.375
• InChiKey: QOOODGUWQNHNMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  49.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  四氢吡咯 、 2-氯-3-(苯基氨基)萘-1,4-二酮 以 二甲基亚砜 为溶剂， 反应 24.0h， 生成 2-(N-anilino)-3-pyrrolidino-1,4-naphthoquinone
  参考文献：
  名称：

  Identification of compounds for the treatment or prevention of proliferative diseases

  摘要：

  这项发明涉及用于治疗癌症和其他增殖性疾病的化合物。这些化合物是在筛选测定中鉴定出来的，该筛选测定将候选化合物与含有包括HER2调节元件和报告基序的核酸的细胞接触。该发明还涉及与筛选测定中鉴定的化合物在结构上相关的化合物。最后，该发明涉及使用该发明的化合物治疗或预防增殖性疾病的方法。

  公开号：

  US20030232801A1

文献信息

• NAPHTHOQUINONE DERIVATIVES USEFUL FOR PREVENTION OF AMYLOID DEPOSITS AND TREATMENT OF DISEASES INVOLVING AMYLOIDOGENESIS
  申请人：Scherzer Roni

  公开号：US20110224184A1

  公开（公告）日：2011-09-15

  The present invention provides pharmaceutical compositions comprising substituted 1,4 naphthoquinones that are effective in preventing oligomerization of beta amyloid and subsequent pathologies associated with amyloid fibrils. These compositions are useful for the treatment of disease involving amyloidogenesis including neurodegenerative diseases such as Alzheimer's Disease or senile dementia. Particularly effective compositions comprise 1,4 naphthoquinones substituted with an amino acid residue selected from a heterocyclic or aromatic amino acid.
• US6630589B1
  申请人：——

  公开号：US6630589B1

  公开（公告）日：2003-10-07
• US9173886B2
  申请人：——

  公开号：US9173886B2

  公开（公告）日：2015-11-03
• US9272993B2
  申请人：——

  公开号：US9272993B2

  公开（公告）日：2016-03-01
• [EN] IDENTIFICATION OF COMPOUNDS FOR THE TREATMENT OR PREVENTION OF PROLIFERATIVE DISEASES<br/>[FR] IDENTIFICATION DE COMPOSES UTILES DANS LE TRAITEMENT OU LA PREVENTION DES MALADIES PROLIFERATIVES
  申请人：MESSAGE PHARMACEUTICALS INC

  公开号：WO2002077609A2

  公开（公告）日：2002-10-03

  The invention features screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element and a reporter sequence. In addition, the invention features compounds identified by the assays of the invention. The invention further features compounds structurally related to those identified by the screening assays. Finally, the invention features methods of treating or preventing a proliferative disease using the compounds of the invention.